Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Tracon Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- +2 vs. Q1 2021
- Shares held
- 9.02M
- −176.0K (−1.9%) vs. Q1 2021
- Total value
- $58.5M
- −$14.3M (−19.6%) vs. Q1 2021
- New holders
- 7
- 6 more added
- Sold out
- 5
- 14 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TCON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 29 | $1.39M |
| Q4 2023 | 24 | $903.4K |
| Q3 2023 | 21 | $1.66M |
| Q2 2023 | 27 | $2.90M |
| Q1 2023 | 32 | $18.8M |
| Q4 2022 | 32 | $14.6M |
| Q3 2022 | 33 | $16.5M |
| Q2 2022 | 31 | $19.7M |
| Q1 2022 | 35 | $24.0M |
| Q4 2021 | 35 | $25.4M |
| Q3 2021 | 45 | $39.6M |
| Q2 2021 | 44 | $58.5M |
| Q1 2021 | 42 | $72.8M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Tracon Pharmaceuticals, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TCI Wealth Advisors, Inc. | 200 | $1.00K | 0.00% | −200−50.0% | Reduced |
| O'Shaughnessy Asset Management, LLC | 182 | $1.00K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 140 | $1.00K | 0.00% | +140 | New |
| Truvestments Capital LLC | 318 | $2.00K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 800 | $5.00K | 0.00% | −300−27.3% | Reduced |
| Advisory Services Network, LLC | 1,000 | $6.00K | 0.00% | +1,000 | New |
| Cutler Group LP | 1,200 | $7.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 2,190 | $14.0K | 0.00% | −648−22.8% | Reduced |
| Lindbrook Capital, LLC | 3,000 | $19.0K | 0.00% | −3,500−53.8% | Reduced |
| Wells Fargo & Company | 8,759 | $57.0K | 0.00% | +3,737+74.4% | Added |
| JPMorgan Chase & Co | 8,972 | $58.0K | 0.00% | +7,052+367.3% | Added |
| Morgan Stanley | 11,527 | $75.0K | 0.00% | −12,471−52.0% | Reduced |
| We Are One Seven, LLC | 11,780 | $76.0K | 0.01% | 00.0% | Unchanged |
| Hoylecohen, LLC | 13,000 | $84.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 13,262 | $86.0K | 0.00% | −1,170−8.1% | Reduced |
| CSS LLC | 14,900 | $97.0K | 0.01% | 00.0% | Unchanged |
| Vigilare Wealth Management | 17,000 | $110.0K | 0.07% | +3,000+21.4% | Added |
| Price T Rowe Associates Inc | 17,400 | $113.0K | 0.00% | −5,000−22.3% | Reduced |
| Northern Trust Corp | 17,337 | $113.0K | 0.00% | +17,337 | New |
| X-Square Capital, LLC | 20,973 | $136.0K | 0.06% | 00.0% | Unchanged |
| ACT Capital Management, LLC | 28,500 | $185.0K | 0.10% | +28,500 | New |
| Susquehanna Fundamental Investments, LLC | 31,616 | $205.0K | 0.00% | −977−3.0% | Reduced |
| Acadian Asset Management LLC | 33,485 | $217.0K | 0.00% | +9,488+39.5% | Added |
| Gsa Capital Partners LLP | 36,370 | $236.0K | 0.03% | +10,720+41.8% | Added |
| Telemetry Investments, L.L.C. | 40,000 | $260.0K | 0.36% | +40,000 | New |
| Dowling & Yahnke LLC | 40,455 | $263.0K | 0.02% | 00.0% | Unchanged |
| QS Investors, LLC | 43,700 | $284.0K | 0.00% | 00.0% | Unchanged |
| Marshall Wace, LLP | 56,351 | $366.0K | 0.00% | −85,010−60.1% | Reduced |
| Dimensional Fund Advisors LP | 57,335 | $372.0K | 0.00% | +57,335 | New |
| State Street Corp | 72,954 | $473.0K | 0.00% | +72,954 | New |
| Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $545.0K | 0.06% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 85,079 | $553.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 137,822 | $894.0K | 0.00% | +32,868+31.3% | Added |
| Renaissance Technologies LLC | 173,535 | $1.13M | 0.00% | −67,065−27.9% | Reduced |
| Two Sigma Investments, LP | 250,059 | $1.62M | 0.00% | −59,428−19.2% | Reduced |
| Deutsche Bank AG | 253,617 | $1.65M | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 284,100 | $1.84M | 0.00% | −23,300−7.6% | Reduced |
| Linden Advisors LP | 284,248 | $1.84M | 0.01% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 294,031 | $1.91M | 0.08% | 00.0% | Unchanged |
| BlackRock Inc. | 294,228 | $1.91M | 0.00% | −31,742−9.7% | Reduced |
| NEA Management Company, LLC | 346,718 | $2.25M | 0.03% | 00.0% | Unchanged |
| Vanguard Group Inc | 689,038 | $4.47M | 0.00% | −4,178−0.6% | Reduced |
| Opaleye Management Inc. | 2,518,371 | $16.3M | 2.71% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 2,716,840 | $17.6M | 3.15% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 0 | $0 | 0.00% | −88,484−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −51,794−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −12,586−100.0% | Sold out |
| Total Clarity Wealth Management, Inc. | 0 | $0 | 0.00% | −6,825−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −5,486−100.0% | Sold out |